Vaginal estrogen for genitourinary syndrome of menopause: a systematic review
DD Rahn, C Carberry, TV Sanses… - Obstetrics & …, 2014 - journals.lww.com
OBJECTIVE: To comprehensively review and critically assess the literature on vaginal
estrogen and its alternatives for women with genitourinary syndrome of menopause and to …
estrogen and its alternatives for women with genitourinary syndrome of menopause and to …
Efficacy and tolerability of local estrogen therapy for urogenital atrophy
DF Archer - Menopause, 2010 - journals.lww.com
Objective: This study aimed to identify vaginal discomfort in the form of dryness, itching,
burning, and dyspareunia, which remains an inadequately addressed clinical problem for …
burning, and dyspareunia, which remains an inadequately addressed clinical problem for …
Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) …
SA Kingsberg, S Wysocki, L Magnus… - The journal of sexual …, 2013 - academic.oup.com
Introduction Vulvar and vaginal atrophy (VVA) is a chronic medical condition experienced by
many postmenopausal women. Symptoms include dyspareunia (pain with intercourse) …
many postmenopausal women. Symptoms include dyspareunia (pain with intercourse) …
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study
S Salvatore, RE Nappi, N Zerbinati, A Calligaro… - …, 2014 - Taylor & Francis
Objective This pilot study aimed to assess the efficacy and feasibility of fractional CO2 laser
in the treatment of vulvovaginal atrophy (VVA) in postmenopausal women. Methods VVA …
in the treatment of vulvovaginal atrophy (VVA) in postmenopausal women. Methods VVA …
A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial
MFR Paraiso, CA Ferrando, ER Sokol, CR Rardin… - Menopause, 2020 - journals.lww.com
Objective: The aim of the study was to compare 6-month efficacy and safety for treatment of
vaginal dryness/genitourinary syndrome of menopause in women undergoing fractionated …
vaginal dryness/genitourinary syndrome of menopause in women undergoing fractionated …
Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial
Importance Nearly half of postmenopausal women report bothersome vulvovaginal
symptoms, but few data support the efficacy of 2 commonly recommended treatments …
symptoms, but few data support the efficacy of 2 commonly recommended treatments …
Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey
RE Nappi, S Palacios, N Panay, M Particco… - …, 2016 - Taylor & Francis
Objectives The aim of the European REVIVE survey was to achieve a better understanding
of vulvovaginal atrophy (VVA), a chronic and progressive condition after menopause. We …
of vulvovaginal atrophy (VVA), a chronic and progressive condition after menopause. We …
An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy
ER Sokol, MM Karram - Menopause, 2016 - journals.lww.com
Objectives: The aim of the study was to assess the safety and efficacy of a novel fractional
CO 2 laser for the treatment of genitourinary syndrome of menopause (GSM). Methods …
CO 2 laser for the treatment of genitourinary syndrome of menopause (GSM). Methods …
Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes
ER Sokol, MM Karram - Menopause, 2017 - journals.lww.com
Objectives: To assess safety and efficacy of a fractional CO 2 laser therapy for the treatment
of genitourinary syndrome of menopause (GSM) with follow-up to 1 year posttreatment …
of genitourinary syndrome of menopause (GSM) with follow-up to 1 year posttreatment …
Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause
F Behnia-Willison, S Sarraf, J Miller… - European Journal of …, 2017 - Elsevier
Objectives To evaluate the safety and long-term efficacy of fractional CO 2 laser treatment in
reducing the severity of symptoms of genitourinary syndrome of menopause (GSM) in …
reducing the severity of symptoms of genitourinary syndrome of menopause (GSM) in …